![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1792304
ºê¶óŰÅ×¶óÇÇ ½ÃÀå º¸°í¼ : ¼ºñ½º À¯Çü, ±â¼ú, Á¶´Þ ¹æ¹ý, ÃÖÁ¾ »ç¿ëÀÚ, Áö¿ªº°(2025-2033³â)Brachytherapy Market Report by Service Type (History and Physical Report, Discharge Summary, Operative Note or Report, Consultation Report, and Others ), Technology, Mode of Procurement, End-User, and Region 2025-2033 |
¼¼°èÀÇ ºê¶óŰÅ×¶óÇÇ ½ÃÀå ±Ô¸ð´Â 2024³â 8¾ï 8,810¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº ½ÃÀåÀÌ 2033³â±îÁö 12¾ï 1,590¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2033³â ¿¬Æò±Õ ¼ºÀå·ü(CAGR)Àº 3.55%¸¦ º¸ÀÏ Àü¸ÁÀÔ´Ï´Ù.
ºê¶óŰÅ×¶óÇÇ(³»ºÎ ¹æ»ç¼± Ä¡·á)´Â ¹æ»ç¼±À» ¾Ï Á¾¾ç ±Ùó³ª ÇâÈÄ ÀÌ½ÄµÈ ¹æ»ç¼±¿øÀ» ÅëÇØ Á÷Á¢ Àü´ÞÇÏ´Â ¹æ»ç¼± Ä¡·áÀÇ ÇÑ ÇüÅÂÀÔ´Ï´Ù. ÀÌ ¿øÀº °¨¸¶¼±À» ¹æÃâÇÏ¿© ¾Ï ¼¼Æ÷¿¡ ÁýÁß½ÃÄÑ ÁÖº¯ °Ç°ÇÑ Á¶Á÷ÀÇ ¼Õ»óÀ» ÃÖ¼ÒÈÇÕ´Ï´Ù. ºê¶óŰÅ×¶óÇÇ´Â Áúº´ÀÇ ½É°¢¼º°ú ¼Õ»ó Á¤µµ¿¡ µû¶ó Àú¼±·®·ü(LDR) ¶Ç´Â °í¼±·®·ü(HDR)·Î Åõ¿©µË´Ï´Ù. LDRÀÇ °æ¿ì, ÀÛÀº ¹æ»ç¼º Á¾ÀÚ°¡ Á¾¾ç ³» ¶Ç´Â ÁÖº¯¿¡ ¿µ±¸ÀûÀ¸·Î À̽ĵǸç, HDRÀÇ °æ¿ì °¢ ¼¼¼Ç Á¾·á ½Ã ȯÀÚÀÇ ¸ö¿¡¼ ¹æ»ç¼º ¿øÀ» Á¦°ÅÇÏ¿© °íÀ§Çè ¾Ï ÀÌ¿ë »ç·Ê¿¡ »ç¿ëµË´Ï´Ù.
´Ù¾çÇÑ À¯ÇüÀÇ ¾Ï ¹ß»ý·ü Áõ°¡°¡ Àü ¼¼°èÀÇ ½ÃÀåÀÇ ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ÀڱðæºÎ¾Ï, ÇǺξÏ, À¯¹æ¾Ï Ä¡·á¿¡ ±ØÈ÷ È¿°úÀûÀÎ Ä¡·á ¿É¼ÇÀ¸·Î ÀÔÁõµÈ ºê¶óŰÅ×¶óÇÇ´Â ½ÃÀå ¼ºÀå¿¡ »ó´çÇÏ°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÛÀº Á¾¾ç¿¡ Á¤È®ÇÏ°í ±ØÈ÷ ±¹¼ÒÈµÈ ¹æ»ç¼± ¿ë·®À» Á¦°øÇÏ´Â °íǰÁú ºê¶óŰÅ×¶óÇÇ ÀåºñÀÇ °¡¿ë¼ºÀº ȯÀÚ ¹× ÀÇ·á Àü¹®°¡ ¸ðµÎ¿¡°Ô Ä¡·á¹ý ¼ö¿ëµµ¸¦ ³ô¿´½À´Ï´Ù. Á¾¾ç Ä¡·á ºÐ¾ßÀÇ ±â¼úÀû ¹ßÀü°ú ±¤¹üÀ§ÇÑ ¿¬±¸ °³¹ß(R&D), ¿¹¸¦ µé¾î ½Å»ýÇ÷°ü¼º ¿¬·É °ü·Ã Ȳ¹Ýº¯¼º Ä¡·á¸¦ À§ÇÑ ÀÓ»ó ½ÃÇè µîÀº ½ÃÀå ¼ºÀå¿¡ »ó´çÇÑ ±â¿©¸¦ Çß½À´Ï´Ù. ¶ÇÇÑ Àü ¼¼°èÀûÀÎ ÀÇ·á °ü±¤ÀÇ Áõ°¡, ºê¶óŰÅ×¶óÇÇÀÇ ÀåÁ¡°ú ¼ö¼ú ¶Ç´Â ¿ÜºÎ ¹æ»ç¼± Ä¡·á(EBT)¿¡ ºñÇØ ºñ¿ë È¿À²¼º°ú Ä¡·áÀ² Çâ»ó µî¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ÀÖ´Â Á¡µµ ½ÃÀå ¼ºÀåÀ» Å©°Ô ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
IMARC GroupÀÇ ÃֽŠº¸°í¼´Â Àü ¼¼°è ºê¶óŰÅ×¶óÇÇ ½ÃÀåÀÇ ¸ðµç Çʼö ¿ä¼Ò¸¦ Æ÷°ýÇÏ´Â ±íÀº ÀλçÀÌÆ®À» Á¦°øÇÕ´Ï´Ù. º» º¸°í¼´Â ½ÃÀå Àü¹ÝÀÇ °Å½ÃÀû °³¿äºÎÅÍ »ê¾÷ ¼º°ú, ÃÖ±Ù Æ®·»µå, ÁÖ¿ä ½ÃÀå ÃËÁø ¿äÀÎ ¹× µµÀü °úÁ¦, SWOT ºÐ¼®, Æ÷ÅÍÀÇ 5·Â ºÐ¼®, °¡Ä¡ »ç½½ ºÐ¼® µî¿¡ À̸£±â±îÁö ´Ù¾çÇÑ ³»¿ëÀ» Æ÷ÇÔÇÕ´Ï´Ù. º» º¸°í¼´Â »ê¾÷ ¾÷ü, ÅõÀÚÀÚ, ¿¬±¸¿ø, ÄÁ¼³ÅÏÆ®, ºñÁî´Ï½º Àü·«°¡, ±×¸®°í Àü ¼¼°è ºê¶óŰÅ×¶óÇÇ ½ÃÀå¿¡ ÁøÃâÇϰųª °ü·Ã °èȹÀ» °¡Áø ¸ðµç À̵鿡°Ô ÇʼöÀûÀÎ ÀÚ·áÀÔ´Ï´Ù.
The global brachytherapy market size reached USD 888.1 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,215.9 Million by 2033, exhibiting a growth rate (CAGR) of 3.55% during 2025-2033.
Brachytherapy, also known as internal radiation therapy, is a form of radiotherapy in which radiation is transported directly through a source implanted near or next to the cancerous tumor in the body. The source produces gamma rays that are focused on cancer cells and reduce the damage to surrounding healthy tissue. Brachytherapy is either administered in Low Dose Rate (LDR) or High Dose Rate (HDR) depending upon the severity of the disease and its damage. For LDR, small radioactive seeds are implanted permanently in or around the tumor, whereas, for HDR, radioactive sources are removed from the patient's body at the termination of each session and is used in the cases of high-risk cancers.
The rising prevalence of different types of cancer is one of the key factors driving the global market. Brachytherapy has been proven to be an extremely effective treatment option for cervical, skin and breast cancers, which is contributing significantly to its market growth. Furthermore, the availability of high-quality brachytherapy equipment that provides accurate and extremely localized doses of radiation to small tumors has enhanced the acceptance of the therapy amongst patients and medical professionals alike. Technological advancements in oncology treatments and extensive research and development (R&D), such as trials for treating neovascular age-related macular degeneration, have also provided a significant boost to the market growth. In addition to this, growing medical tourism across the globe, along with increasing awareness about the advantages of brachytherapy and its cost-effectiveness and increasing cure rate as compared to surgery or external beam therapy (EBT), is also significantly driving the market.
IMARC Group's latest report provides a deep insight into the global brachytherapy market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the global brachytherapy market in any manner.
The report has also analyzed the competitive landscape of the market with some of the key players being Acusis Software India Pvt Ltd., Transcend Services, Inc., Naunce Communications, Inc., MModal Global Services Pvt. Ltd., iMedX Information Services Pvt. Ltd., Global Medical Transcription LLC, nThrive Solutions LLC, MTBC (CareCloud, Inc.), Medi-Script Plus and Transtech Medical Solutions LLC.